Search
for
Sort by
Research 30 of 1000+
- Activity of steroid 4 and derivatives 4a–4f as inhibitors of the enzyme 5α-reductase 1
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- WNT10B (wingless-type MMTV integration site family)
- Diseases of the Canine Prostate Gland
- Two cases of low-prostate-specific antigen localized prostate cancer incidentally detected by computed tomography
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- Transforming growth factor-β in stem cells and tissue homeostasis
- Androgen receptors and their biology
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Is dehydroepiandrosterone a hormone?
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- Redefining hormone resistance in prostate cancer
- Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications
- CXXC5: A novel regulator and coordinator of TGF-β, BMP and Wnt signaling
- News in brief
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- TGFβ and cancer metastasis: an inflammation link
- Case Report: Pulsed electric field treatment of metastatic liver disease demonstrating a possible abscopal response
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs)
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
- PAK4 signaling in health and disease: defining the PAK4–CREB axis